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Introduction
The recognition of symptoms indicative of the risk of dementia in older adults is important, given the prospect of the development of drugs with disease-modifying properties, which would be more efficacious if started in the early stages of the disease.
1 At present, the best attempt to characterize such individuals is the definition of mild cognitive impairment (MCI), which refers to subjects with or without subjective cognitive complaints, objective impairment in cognitive assessment (provided scores are corrected for relation to age and educational level), minimal or no evidence of impairment in the performance of daily activities, and not demented. 2 In most studies, the neuropsychological evaluation remains as the gold standard for diagnosis of MCI. Nonetheless, a comprehensive neuropsychological evaluation is costly, time-consuming, and demands well-trained professionals, thus hindering its widespread use in primary care. Therefore, MCI patients may not be easily recognized in primary clinical settings, delaying the proper identification of subjects with an increased risk of dementia.
Cognitive screening tests can be divided into two broad categories: tests that objectively assess the cognitive performance (e.g. the MiniMental State Examination -MMSE, the Clock Drawing Test), and informant-based questionnaires (e.g. the Informant Questionnaire of Cognitive Decline in the Elderly -IQCODE). The MMSE is the most widely used cognitive screening test and has been validated in several languages and cultures for the diagnostic screening of dementia. The IQCODE is an informant-based questionnaire that compares the patient's present ability to perform several activities of the daily living, and tasks that demand intact recent episodic memory and intellectual abilities over a continuum of 10 years. It is composed of 26 items individually scored from 1-"much better" to 5 -"much worse". Intermediate scores of 2 and 4 indicate slightly better or worse, respectively; score of 3 indicates no significant changes in comparison to 10 years ago. The final score is given by the sum of the 26-item scores divided by 26, and it ranges from 1 to 5, with higher scores indicating worse functional status. 3 The IQCODE is supposedly not unaffected by education, premorbid intellectual ability, or by proficiency in the culture's dominant language. 4 On the other hand, because the IQCODE relies on the information provided by a caregiver or a close relative of the patient, scores may be biased by the informant's cognitive and emotional state (such as depression and anxiety) or personality traits, and by the other factors affecting the relationship between the informant and the patient. These factors can both minimize or maximize the actual deficits. The IQCODE has been shown to have a good sensitivity and specificity to identify cases of dementia, 5 but very few studies have so far addressed the diagnostic properties of the IQCODE in the diagnostic screening of MCI.
Previous reports showed that the association of cognitive screening tests improves the potential of a single test to differentiate individuals with Alzheimer's disease (AD) from unimpaired elderly patients. 6 Therefore, the aim of this work is to ascertain whether the association of two widely used cognitive screening tests, i.e. the MMSE and the IQCODE, is more accurate than each test alone to discriminate cognitively unimpaired elderly subjects from patients with MCI and AD. We hypothesize that the association of these two screening instruments have a higher accuracy in the identification of cognitive impairment than either test alone. Table 1 . Patients were recruited from community sources for the assessment of suspected cognitive decline in São Paulo, Brazil. This study was approved by the Ethical Committee of Hospital das Clínicas University of São Paulo (protocol number: 1032/07), and was performed in accordance with the Helsinki Declaration.
Clinical assessment
The cognitive assessment and the diagnostic procedures in this cohort are described in details in previously published studies. 7 In brief, patients were examined by clinicians specialized in the evaluation of cognitive disorders. The clinical assessment included the Cambridge Mental Disorders of the Elderly Examination (CAMDEX) interview, which yields the Cambridge Cognitive Examination (CAMCOG) and the MMSE scores. The IQCODE was further administered to a close relative or caregiver of each subject. The 21-item Hamilton Depression Scale 8 was administered to rule out depressive symptoms. Evidence of functional decline was suggested by the informant's or the patient's report of difficulties performing activities of daily living. The neuropsychological evaluation was carried out as the gold standard for the diagnosis of MCI and AD as described in previous studies. 9 It included the Rivermead Behavioral Memory Test (RBMT), the Fuld ObjectMemory Evaluation (FOME), the Trail Making Test (TMT) A and B, the Short Cognitive Test (SKT) and the Wechsler Adult Intelligence Scale-Revised (WAIS-R) Vocabulary and Block Design tests. The neuropsychologists responsible for the assessments were blinded to the MMSE and IQCODE scores when the tests were administered. For the sake of conciseness, only the scores for the IQCODE and the MMSE will be reported in this paper (Table 1) .
Diagnosis
Clinical diagnoses were reached by consensus at expert multi-disciplinary meetings, taking into account clinical, neuropsychological, laboratorial, and neuroimaging data. The MMSE and IQCODE scores per se were not taken into account for establishing the clinical diagnosis. Dementia was diagnosed according to the DSM-IV criteria. 10 In this study, we included patients that fulfilled the diagnostic criteria for AD according to the NINCDS-ADRDA 11 or for MCI according to Petersen et al., 12 in addition to cognitively unimpaired age-matched controls. Patients with evidence of depressive or anxiety disorders were excluded from the study, as well as patients with other dementia syndromes, such as vascular dementia and other neurodegenerative diseases, diagnosed according to the currently accepted diagnostic criteria. [13] [14] [15] 4. Statistical analysis Non-parametric statistics were performed to assess median differences between the diagnostic groups (Kruskall Wallis test), while analysis of variance (ANOVA) was performed to control for the variable age. Backward stepwise logistic regression analysis was performed to assess whether the two tests used together provided any additional information for predicting MCI over that given by either test used alone. Receiving Operating Characteristics (ROC) analyses were performed for each test comparing the diagnostic group in a two-by-two fashion. The accuracy of each test, and of their association, is represented by the area under the curve (AUC). In addition, cutoff values and the respective sensitivity and specificity values were drawn by ROC analyses. ROC curves were also constructed for the combination of the tests for MCI accuracy according to the Mackinnon and Mulligan's weighted sum rule. 'Logit (case)' is the logarithm of the odds of a subject being a case of dementia. The IQCODE and the MMSE are the test score values, and the derivation of these values is influenced by the characteristics of the sample.
Weighted sum formula: Logit (case) = 1.4508 + 1.5819 x IQCODE-0.3119 x MMSE.
All statistical analyses were performed using SPSS v14.0 for Windows (SPSS Inc., Chicago, IL) and statistic significance was set at α = 5%. In the logistic regression analysis for the MCI and Control group, using the IQCODE and the MMSE co-variables together, the more the IQCODE scores the higher is the risk of having MCI comparing to lower scores (IQCODE: Odds Ratio (OR): 2.34; p: 0.192; Confidence Interval (CI): 0.65-8.44), but p value is not statistically significant and the wide CI gives less credibility to the results. Only the MMSE was statistically significant in this analysis showing that the lower the score, the higher the risk of having MCI (OR: 0.725; p: 0.001; CI: 0.604-0.871).
Results
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Discussion
Our results showed that although the MMSE and the IQCODE are adequate instruments for the diagnostic screening for dementia, neither test had a good diagnostic accuracy for identification of cases of MCI. In addition, the combined use of these tests did not increase the aforementioned diagnostic properties. Our results are in accordance with previously published studies in which these tests used alone or in combination in the screening for dementia, 17 but are in disagreement with a recent publication by Isella et al., 18 who suggested that the IQCODE had a good discriminative power between cognitively unimpaired older adults and patients with MCI. In this study, with similar cutoff values (28 for the MMSE and 3.19 for the IQCODE), both tests had a similar discriminative accuracy, but higher than in the current sample (AUC: 0.86 and 0.84, respectively). Differences in diagnostic procedures and definitions of cognitive decline may account for the differences in the latter and the current study. In the present sample, the diagnosis of MCI was based on the output of a comprehensive neuropsychological assessment, which probably results in the inclusion of patients with milder degrees of cognitive impairment.
This study highlights two important aspects that may have practical implications for the diagnostic work-up of cognitive disorders. Firstly, the combination of the MMSE and the IQCODE does not seem sufficiently accurate for the identification of cases of MCI, although it is a frequent procedure in clinical practice. Secondly, the diagnosis of MCI still depends on the information provided by a comprehensive neuropsychological assessment.
The complexity of this procedure is a limitation for the largescale diagnosis of MCI, particularly in primary care settings. The diagnosis of MCI is undoubtedly associated with an increased risk of developing dementia in the long-term outcome. However, it is by no means a synonymous of any given neurodegenerative condition. From the clinician's perspective, a careful judgment based on detailed clinical and neuropsychological data, in addition to reliable information on the patient's functional status, preferentially corroborated by longitudinal reassessments, is still the best approach for the detection of relevant cognitive impairment, and to estimate the actual risk of the dementia outcome. 19 
Conclusion
In summary, the IQCODE, the MMSE, and their combined use had low sensitivity for the screening of MCI patients. Therefore, the development of new cognitive screening strategies are mandatory for the identification of such cases and further analyses, in this population, are underway to evaluate which of the 26 IQCODE questions or clusters of them better characterize the MCI patients and its subtypes. 
